Escitalopram Treatment of Night Eating Syndrome

Completed · Not applicable · Has a placebo group

Conditions studied: Night Eating Syndrome

In brief

Night-Eating Syndrome (NES) is an eating disorder characterised by excessive eating at night, sleep disturbance and morning anorexia. This 12-week study examines the effect of escitalopram on symptoms of NES.

Key facts

Study ID

NCT00636649

Run by

Duke University

People needed

40

Starts

2008-10-01

Expected to finish

2011-07-01

Last updated by the study team

2016-06-29

Who can join

Age: 18 and older, up to 70. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Age 18-70 years
• Presence of NES
• BMI 25-50

You may not qualify if…

• History of schizophrenia or other psychoses
• History of bipolar disorder, anorexia nervosa, bulimia, binge eating disorder
• Current major depressive disorder
• Suicidal ideation
• Psychotropic drugs in the past month
• Drugs or herbal remedies that significantly affect body weight, current participation in a weight loss program, currently following a specialized diet (e.g., Atkins, Zone, etc)
• Lack of benefit with SSRI treatment for NES
• Serious or unstable medical illness
• Allergy or hypersensitivity to escitalopram
• Pregnant, breast-feeding, or planning pregnancy in the next six months.

Where it is running

• Saint Louis University — St Louis, Missouri, United States
• Duke University Medical Center — Durham, North Carolina, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.